Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 7/20 | 0.49 |
| ▸ | KDR | P35968 | 7/20 | 0.49 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.49 |
| ▸ | TLK2 | Q86UE8 | 1/20 | 0.49 |
| ▸ | FLT1 | P17948 | 2/20 | 0.44 |
| ▸ | PIM1 | P11309 | 3/20 | 0.43 |
| ▸ | FLT3 | P36888 | 6/20 | 0.42 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.42 |
| ▸ | CSF1R | P07333 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.41 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.41 |
| ▸ | MET | P08581 | 1/20 | 0.41 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.41 |
| ▸ | KIT | P10721 | 3/20 | 0.40 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | MITF | O75030 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6321236 | 0.90 | PDGFRB (0.51) | PDGFRBKDRFGFR1TLK2FLT1 | |
| SCHEMBL6321750 | 0.86 | KDR (0.53) | PDGFRBKDRFGFR1TLK2FLT1 | |
| SCHEMBL6328657 | 0.86 | PDGFRB (0.46) | PDGFRBKDRFGFR1TLK2FLT1 | |
| SCHEMBL6320259 | 0.86 | KDR (0.52) | PDGFRBKDRFGFR1TLK2FLT1 | |
| SCHEMBL6327454 | 0.82 | FLT1 (0.47) | PDGFRBKDRFGFR1FLT1FLT3 | |
| SCHEMBL6330152 | 0.81 | FLT1 (0.45) | PDGFRBKDRFGFR1FLT1FLT3 | |
| SCHEMBL6321746 | 0.80 | KDR (0.55) | PDGFRBKDRFGFR1TLK2FLT1 | |
| SCHEMBL6322071 | 0.80 | FLT1 (0.47) | PDGFRBKDRFGFR1FLT1FLT3 | |
| SCHEMBL6324752 | 0.80 | FLT1 (0.44) | PDGFRBKDRFGFR1FLT1FLT3 | |
| SCHEMBL6321232 | 0.79 | FLT1 (0.44) | PDGFRBKDRFGFR1FLT1FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6861418-B2 | 4-aryl substituted indolinones | SUGEN, INC. (US) | 2005-03-01 | — | — | US | disclosed |
| US-20040157909-A1 | 4-Aryl substituted indolinones | SUGEN, INC. | 2004-08-12 | — | — | US | disclosed |
| US-6677368-B2 | 4-aryl substituted indolinones | SUGEN, INC. | 2004-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157909-A1 | 4-Aryl substituted indolinones | CDK5, CAMK4, TNK2 | PDGFRB 575/4885KDR 819/4885FGFR1 525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.